SFX by Ex Libris Inc.

Title:	sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
Source:	Nature [0028-0836] Kaur, A yr:2016

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	"In‐transit melanoma metastases." International journal of dermatology. 58.7: 844-845.
description	2.	Pascual, G. "Targeting metastasis-initiating cells through the fatty acid receptor CD36." Nature 541.7635 (2016): 41-45.
description	3.	Lauby Secretan, B. "Body Fatness and Cancer - Viewpoint of the IARC Working Group." The New England Journal of Medicine 375.8 (2016): 794-798.
description	4.	Pérez Mancera, Pedro A. "Inside and out : the activities of senescence in cancer." Nature Reviews. Cancer 14.8 (2014): 547-558.
description	5.	McAuliffe, Shannon M. "Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy." Proceedings of the National Academy of Sciences of the United States of America 109.43 (2012): 2939-48.
description	6.	Jessen, Kristjan R. "The Role of Cell Plasticity in Tissue Repair: Adaptive Cellular Reprogramming." Developmental cell 34.6 (2015): 613-20.
description	7.	Renehan, Andrew G G. "Body-mass index and incidence of cancer: a systematic review and meta- analysis of prospective observational studies." Lancet, The 371.9612 (2008): 569-78.
description	8.	van den Brandt, D J A. "Pooled Analysis of Prospective Cohort Studies on Height, Weight, and Breast Cancer Risk." American journal of epidemiology 152.6 (2000): 514-27.
description	9.	"ABCB5 promotes melanoma metastasis through enhancing NF-κB p65 protein stability." Biochemical and biophysical research communications. 492.1: 18-26.
description	10.	"Skin protection behaviour and sex differences in melanoma location in patients with multiple primary melanomas." Australasian journal of dermatology. 58.1: 25-29.
description	11.	Schadendorf, D. "Treatment in metastatic melanoma - Time to re-think." Annals of oncology 30.4 (2019): 501-503.
description	12.	"Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells." Medical sciences. 5.4: 28-.
description	13.	Kircher, David A. "Melanoma Brain Metastasis: Mechanisms, Models, and Medicine." International journal of molecular sciences 17.9 (2016): 1468-.
description	14.	Alsaker, M D K D. "Weight change in adulthood and risk of postmenopausal breast cancer: the HUNT study of Norway." British Journal of Cancer 109.5 (2013): 1310-1317.
description	15.	Matulonis, Ursula A. "Profiles of genomic instability in high-grade serous ovarian cancer predict treatment outcome." Clinical cancer research 18.20 (2012): 5806-5815.
description	16.	Aguilar-Gallardo, C. "Overcoming Challenges of Ovarian Cancer Stem Cells: Novel Therapeutic Approaches." Stem Cell Reviews and Reports 8.3 (2012): 994-1010.
description	17.	Li, X. "Comparative mRNA and microRNA Expression Profiling of Three Genitourinary Cancers Reveals Common Hallmarks and Cancer-Specific Molecular Events." PLoS ONE 6.7 (2011): 1-10.
description	18.	Biddle, A. "Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative." Cancer research 71.15 (2011): 5317-5326.
description	19.	Weinberg, Robert A. "Hallmarks of cancer: the next generation." Cell 144.5 (2011): 646-674.
description	20.	Dhar, S. "Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo." Proceedings of the National Academy of Sciences of the United States of America 108.5 (2011): 1850-1855.